Abstract
The purpose of the present study was to investigate whether the cannabinoid and cholinergic systems impair working memory through a common mechanism. This hypothesis was tested by examining whether the cannabinoid antagonist SR141716A would ameliorate radial-arm performance deficits caused by either the naturally occurring cannabinoid, Δ9-THC, or scopolamine, a muscarinic antagonist. In addition, we evaluated whether the cholinesterase inhibitor, physostigmine, would prevent Δ9-THC-induced impairment of spatial memory. Finally, because the locomotor suppressive effects of cannabinoids may decrease radial arm choice accuracy independent of a direct effect on memory, we examined the impact of increasing the intertrial error on radial arm choice accuracy. As previously reported, Δ9-THC impaired maze performance (ED50=3.0 mg/kg). Increasing the intertrial interval from 5 s to 30 s resulted in a three-fold increase in the amount of time required to complete the maze without affecting choice accuracy. Importantly, SR141716A prevented Δ9-THC-induced deficits in radial-arm choice accuracy in a dose-dependent manner (AD50=2.4 mg/kg); however, the cannabinoid antagonist failed to improve the disruptive effects of scopolamine. Conversely, physostigmine failed to improve performance deficits produced by Δ9-THC. These data provide strong evidence that Δ9-THC impairs working memory through direct action at cannabinoid receptors. Moreover, these results suggest that scopolamine and Δ9-THC do not impair spatial memory in a common serial pathway, though they may converge on a third neurochemical system.
Similar content being viewed by others
References
Abel EL (1971) Retrieval of information after use of marihuana. Nature 231: 58
Carlini EA, Hamaoui A, Bieniek D, Korte F (1970) Effects of (−)Δ9-trans-tetrahydrocannabinol and a synthetic derivative on maze performance of rats. Pharmacology 4: 359–368
Collins DR, Pertwee RG, Davies SN (1995) Prevention by the cannabinoid antagonist, SR141716A, of cannabinoid-meidated blockade of long-term potentiation in the rat hippocampal slice. Br J Pharmacol 115: 869–870
Compton DR, Gold LH, Ward SJ, Balster RL, Martin BR (1992a) Aminoalkylindole analogs: Cannabimimetic activity of a class of compounds structurally distinct from Δ9-tetrahydrocannabinol. J Pharmacol Exp Ther 263: 1118–1126
Compton DR, Johnson MR, Melvin LS, Martin BR (1992) Pharmacological profile of a series of bicyclic cannabinoid analogs — classification as cannabimimetic agents. J Pharmacol Exp Ther 260: 201–209
Compton DR, Rice KC, Costa BRd, Razdan RK, Melvin LS, Johnson MR, Martin BR (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J Pharmacol Exp Ther 265: 218–226
Compton DR, Aceto MD, Lowe J, Martin BR (1996) In vivo characterization of a specific cannabinoid receptor antagonist (SR141716A): inhibition of Δ9-tetrahydrocannabinol-induced responses and apparent agonist activity. J Pharmacol Exper Ther 277: 586–594
Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (1993) Anandamide, and endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46: 967–972
Dennes RP, Barnes JC (1993) Attenuation of scopolamine-induced spatial memory deficits in the rat by cholinomimetic and noncholinomimetic drugs using a novel task in the 12-arm radial maze. Psychopharmacology 111: 435–441
Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46: 791–796
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946–1949
Dewey WL (1986) Cannabinoid pharmacology. Pharmacol Rev 38: 151–78
Evans EB, Wenger GR (1992) Effects of drugs of abuse on acquistion of behavioral chains in squirrel monkeys. Psychopharmacology 107: 55–60
Ferraro DP, Grilly DM (1973) Lack of tolerance to Δ9-tetrahydrocannabinol in chimpanzees. Science 179: 490–492
Ferri S, Costa G, Murari G, Panico AM, Rapisarda E, Speroni E, Arrigo RR (1981) Investigations on behavioral effects of an extract of Cannabis sativa L. in the rat. Psychopharmacology 75: 144–147
Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantative in vitro autoradiographic study. J Neurosci 11: 563–583
Heyser CJ, Hampson RE, Deadwyler SA (1993) Effects of delta9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells. J Pharmacol Exp Ther 264: 294–307
Levin ED, Rose JE (1991) Interactive effects of D1 and D2 agonists with scopolamine on radial-arm maze performance. Pharmacol Biochem Behav 38: 243–246
Lichtman AH, Dimen KR, Martin BR (1995) Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats. Psychopharmacology 119: 282–290
Little PJ, Compton DR, Johnson MR, Melvin LS, Martin BR (1988) Pharmacology and stereoselectivity of structurally novel cannabinoids in mice. J Pharmacol Exp Ther 247: 1046–1051
Martin BR (1986) Cellular effects of cannabinoids. Pharmacol Rev 38: 45–74
Matsuoka N, Maeda N, Ohkubo Y, Yamaguchi I (1991) Differential effects of physostigmine and pilocarpine on the spatial memory deficits produced by two septo-hippocampal deafferentations in rats. Brain Res 559: 233–240
McConnell WR, Dewey WL, Harris LS, Borzelleca JF (1978) A study of the effect of delta9-tetrahydrocannabinol (delta9-THC) on mammalian salivary flow. J Pharmacol Exp Ther 206: 567–573
McGurk SR, Levin ED, Butcher LL (1991) Impairment of radialarm maze performance in rats following lesions involving the cholinergic medial pathway: reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience 44: 137–147
McGurk SR, Levin ED, Butcher LL (1992) Dopaminergic drugs reverse the impairment of radial-arm maze performance caused by lesions involving the cholinergic medial pathway. Neuroscience 50: 129–135
Murray CL, Fibiger BC (1985) Learning and memory deficits after lesions of the nucleus basalis magnocellularis: reversal by physostigmine. Neuroscience 14: 1025–1032
Nakamura EM, da Silva EA, Concilio GV, Wilkinson DA, Masur J (1991) Reversible effects of acute and long-term administration of Δ9-tetrahydrocannabinol (THC) on memory in the rat. Drug Alcohol Depend 28: 167–175
Olton DS (1987) The radial arm maze as a tool in behavioral pharmacology. Physiol Behav 40: 793–797
Paton WDM, Aboo Zar M (1968) The origin of acetylcholine released from guinea-pig intestine and longitudinal muscle strips. J Physiol 194: 13–33
Pertwee RG, Ross TM (1991) Drugs which stimulate or facilitate central cholinergic transmission interact synergistically with Δ9-tetrahydrocannabinol to produce marked catalepsy in mice. Neuropharmacology 30: 67–71
Prescott WR, Gold LH, Martin BR (1992) Evidence for separate neuronal mechanisms for the discriminative stimulus and catalepsy induced by Δ9-THC in the rat. Psychopharmacology 107: 117–124
Revuelta AV, Cheney DL, Costa E, Lander N, Mechoulam R (1980) Reduction of hippocampal acetylcholine turnover in rats treated with (-)-delta 8-tetrahydrocannabinol and its 1′,2′-dimethyl-heptyl homolog. Brain Res 195: 445–452
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Calandra B, Congy C, Martinez S, Maruani J, Néliat G, Caput D, Ferrara P, Soubrié P, Brelière JC, Le Fur G (1994) SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 350: 240–244
Rinaldi-Carmona M, Barth F, Héaulme M, Shire D, Alonso R, Congy C, Soubrié P, Brelière JC, Le Fur G (1995) Biochemical and pharmacological characterization of SR141716A, the first potent and selective brain cannabinoid receptor antagonist. Life Sci 56: 1941–1947
Tallarida RJ, Murray RB (1987) Manual of pharmacologic calculations with computer programs, 2nd edn. Springer, New York
Tilson HA, McLamb RL, Shaw S, Rogers BC, Pediatitakis P, Cook L (1988) Radial-arm maze deficits produced by colchicine administered into the area of the nucleus basalis are ameliorated by cholinergic agents. Brain Res 438: 83–94
Tripathi HL, Vocci FJ, Brase DA, Dewey WL (1987) Effects of cannabinoids on levels of acetylcholine and choline and on turnover rate of acetylcholine in various regions of the mouse brain. Alcohol Drug Res 7: 525–532
Westlake TM, Howlett AC, Bonner TI, Matsuda LA, Herkenham M (1994) Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains. Neuroscience 63: 637–652
Wiley JL, Lowe J, Balster RL, Martin BR (1995a) Antagonism of the discriminative stimulus effects of Δ9-THC in rats and rhesus monkeys. J Pharmacol Exp Ther 275: 1–6
Wiley JL, Barrett RL, Lowe J, Balster RL, Martin BR (1995b) Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34: 669–676
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lichtman, A.H., Martin, B.R. Δ9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126, 125–131 (1996). https://doi.org/10.1007/BF02246347
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246347